Archives: “Experimental Platforms & Models”

Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity

https://www.coltonconsortium.org/publications/racial-and-ethnic-determinants-of-psoriatic-arthritis-phenotypes-and-disease-activity/

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

https://www.coltonconsortium.org/publications/crizanlizumab-for-retinal-vasculopathy-with-cerebral-leukoencephalopathy-in-a-phase-ii-clinical-study/

Decoding immunobiology through genetic errors of immunity

https://www.coltonconsortium.org/publications/decoding-immunobiology-through-genetic-errors-of-immunity/

Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome

https://www.coltonconsortium.org/publications/description-of-a-novel-splice-site-variant-in-uba1-gene-causing-vexas-syndrome/

Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis

https://www.coltonconsortium.org/publications/diagnostic-performance-of-central-vein-sign-versus-oligoclonal-bands-for-multiple-sclerosis/

Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort

https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/

Divergent ontogeny of tissue resident memory and tissue resident exhausted CD8+ T cells underlies distinct functional potential

https://www.coltonconsortium.org/publications/divergent-ontogeny-of-tissue-resident-memory-and-tissue-resident-exhausted-cd8-t-cells-underlies-distinct-functional-potential/

Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies

https://www.coltonconsortium.org/publications/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-psoriatic-arthritis-1-year-results-from-two-phase-3-studies/

Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial

https://www.coltonconsortium.org/publications/efficacy-and-safety-of-avacopan-in-patients-aged-65-years-and-older-with-anca-associated-vasculitis-a-post-hoc-analysis-of-data-from-the-advocate-trial/

EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases

https://www.coltonconsortium.org/publications/egfr-stat1-pathway-drives-fibrosis-initiation-in-fibroinflammatory-skin-diseases/